These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9844425)

  • 1. Identifying psychophysiological risk for psychopathology: examples from substance abuse and schizophrenia research.
    Iacono WG
    Psychophysiology; 1998 Nov; 35(6):621-37. PubMed ID: 9844425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New strategies in schizophrenia: impact of endophentotypes].
    Opgen-Rhein C; Neuhaus A; Urbanek C; Dettling M
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S194-9. PubMed ID: 15586310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychophysiological aspects of schizophrenia: a selective review.
    Knott VJ
    Psychiatr J Univ Ott; 1983 Jun; 8(2):51-66. PubMed ID: 6351142
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychophysiologic abnormalities in schizophrenia: some implications for therapy].
    Andres K; Brenner HD
    Z Exp Angew Psychol; 1990; 37(4):565-79. PubMed ID: 2288131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early visual processing deficits in dysbindin-associated schizophrenia.
    Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ
    Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain activation during antisaccades in unaffected relatives of schizophrenic patients.
    Raemaekers M; Ramsey NF; Vink M; van den Heuvel MP; Kahn RS
    Biol Psychiatry; 2006 Mar; 59(6):530-5. PubMed ID: 16165103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA-axis activity in alcoholism: examples for a gene-environment interaction.
    Clarke TK; Treutlein J; Zimmermann US; Kiefer F; Skowronek MH; Rietschel M; Mann K; Schumann G
    Addict Biol; 2008 Mar; 13(1):1-14. PubMed ID: 17910738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychophysiology of schizophrenic disorders of attention--concepts, findings and working hypotheses].
    Ulrich G; Gaebel W
    Fortschr Neurol Psychiatr; 1987 Sep; 55(9):279-88. PubMed ID: 3311950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P300 and genetic risk for schizophrenia.
    Winterer G; Egan MF; Raedler T; Sanchez C; Jones DW; Coppola R; Weinberger DR
    Arch Gen Psychiatry; 2003 Nov; 60(11):1158-67. PubMed ID: 14609891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there any point in detecting high risk factors prior to a first psychosis?].
    Klaassen MC; Nieman DH; Becker HE; Linszen DH
    Tijdschr Psychiatr; 2006; 48(6):467-76. PubMed ID: 16956006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criminality in men with major mental disorder with and without comorbid substance abuse.
    Modestin J; Wuermle O
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):25-9. PubMed ID: 15679536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder.
    Erkiran M; Ozünalan H; Evren C; Aytaçlar S; Kirisci L; Tarter R
    Addict Behav; 2006 Oct; 31(10):1797-805. PubMed ID: 16457960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antisaccade task as a research tool in psychopathology: a critical review.
    Hutton SB; Ettinger U
    Psychophysiology; 2006 May; 43(3):302-13. PubMed ID: 16805870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons for increased substance use in psychosis.
    Gregg L; Barrowclough C; Haddock G
    Clin Psychol Rev; 2007 May; 27(4):494-510. PubMed ID: 17240501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
    Corvin A; Donohoe G; McGhee K; Murphy K; Kenny N; Schwaiger S; Nangle JM; Morris D; Gill M
    Neurosci Lett; 2007 Oct; 426(2):97-100. PubMed ID: 17890006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.
    Donohoe G; Morris DW; Clarke S; McGhee KA; Schwaiger S; Nangle JM; Garavan H; Robertson IH; Gill M; Corvin A
    Neuropsychologia; 2007 Jan; 45(2):454-8. PubMed ID: 16930638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.